 |
市场调查报告书
商品编码
1567271
胃肠病学市场：依药物类型、剂型、疾病类型、通路、地区分类Gastroenterology Market, By Drug Type, By Dosage Form, By Disease Type, By Distribution Channel, By Geography |
||||||
全球胃肠病学市场预计到2024年将达到351.2亿美元，预计到2031年将达到531亿美元，2024年至2031年的复合年增长率为6.1%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 351.2亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024年至2031年 |
| 预测 2024-2031 年复合年增长率： | 6.10% | 2031年价值预测 | 531亿美元 |
全球胃肠病学市场的成长是由胃溃疡、发炎性肠道疾病肠道疾病和大肠激躁症等胃肠道疾病的增加以及需要有效诊断和治疗解决方案的老年人口的增加所推动的。此外，胃肠内视镜设备的技术进步和胃肠疾病新药的市场开拓也将支持市场成长。各个市场参与者正在推出新产品并扩大业务，以满足医疗机构和患者不断增长的需求。先进胃肠道医疗设备的高昂成本以及低收入国家缺乏认知可能对让患者更广泛地获得医疗保健构成挑战。
市场动态：
全球胃肠病学市场的成长是由全球胃肠道疾病盛行率增加、易患胃肠道疾病的老年人口增加以及胃肠道医疗设备的进步等因素所推动的。然而，胃肠仪器和内视镜设备的高成本可能会阻碍市场成长。针对胃肠道问题的新型口服药物的出现以及新兴市场医疗保健基础设施的开拓可以为市场扩张提供机会。北美因其庞大的患者群体、创新治疗方法的快速核准以及市场参与企业的战略倡议而在全球胃肠病学市场中占据主导地位。然而，由于中国和印度等国家获得专业医疗保健的机会有所改善，预计亚太地区将出现更高的成长。
（本次调查的主要特点）
该报告对全球胃肠病学市场进行了详细分析，并以 2023 年为基准年估计了预测期内（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球胃肠病学市场的主要企业。
本研究涉及的主要企业包括美敦力、强生、雅培、罗氏、拜耳、葛兰素史克、赛诺菲、辉瑞和诺华。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
胃肠病学市场的全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球胃肠病学市场的各种策略矩阵，将有助于相关人员做出决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球胃肠病学市场 - 冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球胃肠病学市场，依药物类型，2019-2031（十亿美元）
- 生技药品/生物相似药
- 制酸剂
- 泻药
- 止泻药
- 止吐药
- 抗溃疡剂
- 其他的
第六章全球胃肠病学市场，按剂型，2019-2031（十亿美元）
- 口服
- 胃肠外的
- 其他的
第七章全球胃肠病学市场，依疾病类型，2019-2031（十亿美元）
- 发炎性肠道疾病（IBD）
- 克隆氏症
- 溃疡性大肠炎
- 大肠激躁症（IBS）
- 胃食道逆流症（GERD）
- 肝臟疾病
- 大肠直肠癌
- 其他（消化性溃疡等）
第 8 章全球胃肠病学市场，按分销管道划分，2019-2031 年（十亿美元）
- 医院药房
- 零售药房
- 网路药房
第 9 章全球胃肠病学市场，按地区，2019-2031 年（十亿美元）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 北非
- 中部非洲
- 南非
第10章竞争格局
- 公司简介
- Allied Digestive Health
- Boston Scientific
- Capital Digestive Care
- CRH Medical
- Iterative Scopes
- Fujifilm Medical
- Gastro Health
- GI Alliance
- Medtronic
- Micro-Tech Endoscopy
- Motus GI
- Olympus
- One GI
- PE GI Solutions
- Peak Gastroenterology Associates
- Pentax Medical
- Pinnacle GI Partners
- Saneso
- Surgical Innovations
- Wision AI
第十一章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十二章调查方法
- 参考
- 调查方法
Global gastroenterology market is estimated to be valued at USD 35.12 Bn in 2024 and is expected to reach USD 53.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 35.12 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 6.10% | 2031 Value Projection: | US$ 53.10 Bn |
Global gastroenterology market growth is driven by rising gastrointestinal disorders such as stomach ulcer, inflammatory bowel disease, irritable bowel syndrome and growing geriatric population that requires effective diagnosis and treatment solutions. Furthermore, technological advancements in gastrointestinal endoscopy devices along with development of novel drugs for gastrointestinal issues can also drive the market growth. Various market players are engaged in new product launches and expansions to cater to increasing needs of healthcare facilities as well as patients. High costs associated with advanced gastroenterology devices and lack of awareness in low-income nations can pose challenges for broader patient access to care.
Market Dynamics:
Global gastroenterology market growth is driven by factors like growing prevalence of gastrointestinal disorders worldwide, increasing geriatric population susceptible to digestive diseases, and advancements in gastrointestinal medical devices. However, high costs associated with gastrointestinal instrumentation and endoscopy devices can hamper the market growth. Emergence of novel oral medicines for gastrointestinal issues and developing healthcare infrastructure in emerging nations can present lucrative opportunities for market expansion. North America dominates the global gasteroenterology market, owing to sizable patient population, fast approval of innovative therapies, and strategic initiatives by market players. However, Asia Pacific is expected to offer high growth prospects due to improving access to specialty care in nations like China and India.
(Key features of the study):
This report provides in-depth analysis of the global gastroenterology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gastroenterology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Johnson & Johnson, Abbott Laboratories, Hoffmann-La Roche, Bayer AG, GlaxoSmithKline, Sanofi, Pfizer, and Novartis AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global gastroenterology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gastroenterology market
Detailed Segmentation-
- By Drug Type Insights (Revenue, USD Bn, 2019 - 2031)
- Biologics/Biosimilars
- Antacids
- Laxatives
- Antidiarrheal Agents
- Antiemetics
- Antiulcer Agents
- Others
- By Dosage Form Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Others
- By Disease Type Insights (Revenue, USD Bn, 2019 - 2031)
- Inflammatory Bowel Diseases (IBD)
- Crohn's Disease
- Ulcerative Colitis
- Irritable Bowel Syndrome (IBS)
- Gastroesophageal Reflux Disease (GERD)
- Liver Diseases
- Colorectal Cancer
- Others (Peptic Ulcers, etc.)
- By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Allied Digestive Health
- Boston Scientific
- Capital Digestive Care
- CRH Medical
- Iterative Scopes
- Fujifilm Medical
- Gastro Health
- GI Alliance
- Medtronic
- Micro-Tech Endoscopy
- Motus GI
- Olympus
- One GI
- PE GI Solutions
- Peak Gastroenterology Associates
- Pentax Medical
- Pinnacle GI Partners
- Saneso
- Surgical Innovations
- Wision A.I.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Dosage Form
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Gastroenterology Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Gastroenterology Market, By Drug Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Biologics/Biosimilars
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antacids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Laxatives
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antidiarrheal Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antiemetics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antiulcer Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Gastroenterology Market, By Dosage Form, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Gastroenterology Market, By Disease Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Inflammatory Bowel Diseases (IBD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Crohn's Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ulcerative Colitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Irritable Bowel Syndrome (IBS)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Gastroesophageal Reflux Disease (GERD
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Liver Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others (Peptic Ulcers, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Gastroenterology Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Gastroenterology Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Allied Digestive Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific
- Capital Digestive Care
- CRH Medical
- Iterative Scopes
- Fujifilm Medical
- Gastro Health
- GI Alliance
- Medtronic
- Micro-Tech Endoscopy
- Motus GI
- Olympus
- One GI
- PE GI Solutions
- Peak Gastroenterology Associates
- Pentax Medical
- Pinnacle GI Partners
- Saneso
- Surgical Innovations
- Wision A.I.
- Allied Digestive Health
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. Research Methodology
- References
- Research Methodology
- About us and Sales Contact
西尼必利市场：按剂型、通路、应用分类 - 2025-2030 年全球预测
Benexate 市场：按产品类型、配方、应用和最终用户划分 - 全球预测 2025-2030
胃动力障碍药物市场（药物类别：抗酸剂、止泻药、钙通道阻断剂；以及疾病类型：上消化道和下消化道）- 全球产业分析、规模、份额、成长、趋势和预测，2024 -2034 年
消化不良药物市场：按类型、药物类型、分销管道划分 - 全球预测 2024-2030
胃肠道药物市场：按类型、疾病类型、给药途径、分销管道、最终用户分类 - 全球预测 2024-2030
胃肠道诊断市场 - 按测试类型、技术、应用、最终用途和全球预测
阑尾炎治疗市场（类型：急性阑尾炎和慢性阑尾炎；以及治疗：手术、药物等）- 2024-2034 年全球行业分析、规模、份额、成长、趋势和预测
全球阑尾炎治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测
胃动力障碍药物市场，按疾病类型，按药物类别，按配销通路，按地理位置
胃肠疾病治疗药物市场：配销通路、给药途径和应用划分 - 全球预测 2024-2030